Simplex Trading, LLC Delcath Systems, Inc. Transaction History
Simplex Trading, LLC
- $195 Billion
- Q3 2025
A detailed history of Simplex Trading, LLC transactions in Delcath Systems, Inc. stock. As of the latest transaction made, Simplex Trading, LLC holds 20,029 shares of DCTH stock, worth $178,858. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,029
Previous 6,505
207.9%
Holding current value
$178,858
Previous $88,000
144.32%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding DCTH
# of Institutions
129Shares Held
13MCall Options Held
133KPut Options Held
159K-
Vanguard Group Inc Valley Forge, PA1.66MShares$14.8 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA688KShares$6.14 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT666KShares$5.95 Million0.29% of portfolio
-
State Street Corp Boston, MA621KShares$5.55 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA570KShares$5.09 Million0.97% of portfolio
About DELCATH SYSTEMS, INC.
- Ticker DCTH
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 8,597,680
- Market Cap $76.8M
- Description
- Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan hydrochloride for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling syste...